B6.Cg-Pik3c3tm1Bvan/H

Status

Available to order

EMMA IDEM:13251
Citation informationRRID:IMSR_EM:13251 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6.Cg-Pik3c3tm1Bvan/H
Alternative nameVps34-flox
Strain typeTargeted Mutant Strains : Conditional mutation
Allele/Transgene symbolPik3c3tm1Bvan
Gene/Transgene symbolPik3c3

Information from provider

ProviderBart Vanhaesebroeck
Provider affiliationUniversity College London
Genetic informationExon 21 of the kinase domain of the Pik3c3 (Vps34) gene was flanked by loxP sites. This exon encodes a critical stretch of 25 amino acids (Ala730 to Thr754) in the VPS34 kinase domain, producing an in-frame deletion upon Cre-mediated recombination, generating a truncated version of VPS34 which is catalytically inactive (Supplementary Fig S1A, B in Frontiers in Immunology;15;1374621; PMID: 39664390).
Phenotypic informationHomozygous:
Mice are phenotypically normal.

Heterozygous:
Mice are phenotypically normal.
Breeding historyBackcrossed onto C57BL/6J for more than 10 generations.
References
  • Vps34/PI3KC3 deletion in kidney proximal tubules impairs apical trafficking and blocks autophagic flux, causing a Fanconi-like syndrome and renal insufficiency.;Grieco Giuseppina, Janssens Virginie, Gaide Chevronnay Héloïse P, N'Kuli Francisca, Van Der Smissen Patrick, Wang Tongsong, Shan Jingdong, Vainio Seppo, Bilanges Benoit, Jouret François, Vanhaesebroeck Bart, Pierreux Christophe E, Courtoy Pierre J, ;2018;Scientific reports;8;14133; 30237523
  • A dual role for the class III PI3K, Vps34, in platelet production and thrombus growth.;Valet Colin, Levade Marie, Chicanne Gaëtan, Bilanges Benoit, Cabou Cendrine, Viaud Julien, Gratacap Marie-Pierre, Gaits-Iacovoni Frédérique, Vanhaesebroeck Bart, Payrastre Bernard, Severin Sonia, ;2017;Blood;130;2032-2042; 28903944
  • Lack of phosphatidylinositol 3-kinase VPS34 in regulatory T cells leads to a fatal lymphoproliferative disorder without affecting their development.;Courreges Christina J F, Davenport Elizabeth C M, Bilanges Benoit, Rebollo-Gomez Elena, Hukelmann Jens, Schoenfelder Priya, Edgar James R, Sansom David, Scudamore Cheryl L, Roychoudhuri Rahul, Garden Oliver A, Vanhaesebroeck Bart, Okkenhaug Klaus, ;2024;Frontiers in immunology;15;1374621; 39664390
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

IMPC phenotypes (gene matching)
  • preweaning lethality, complete penetrance / IMPC
  • decreased circulating triglyceride level / IMPC
  • decreased grip strength / IMPC
  • preweaning lethality, incomplete penetrance / IMPC
  • abnormal tail movements / IMPC
MGI phenotypes (gene matching)
  • decreased cell proliferation / MGI
  • absent mesoderm / MGI
  • failure of primitive streak formation / MGI
  • failure to gastrulate / MGI
  • decreased embryo size / MGI
  • embryonic growth arrest / MGI
  • no abnormal phenotype detected / MGI
  • abnormal embryonic epiblast morphology / MGI
  • embryonic growth retardation / MGI
  • disorganized embryonic tissue / MGI
  • cellular phenotype / MGI
  • embryonic lethality between implantation and placentation, complete penetrance / MGI
  • abnormal visceral endoderm morphology / MGI

Literature references

  • Vps34/PI3KC3 deletion in kidney proximal tubules impairs apical trafficking and blocks autophagic flux, causing a Fanconi-like syndrome and renal insufficiency.;Grieco Giuseppina, Janssens Virginie, Gaide Chevronnay Héloïse P, N'Kuli Francisca, Van Der Smissen Patrick, Wang Tongsong, Shan Jingdong, Vainio Seppo, Bilanges Benoit, Jouret François, Vanhaesebroeck Bart, Pierreux Christophe E, Courtoy Pierre J, ;2018;Scientific reports;8;14133; 30237523
  • A dual role for the class III PI3K, Vps34, in platelet production and thrombus growth.;Valet Colin, Levade Marie, Chicanne Gaëtan, Bilanges Benoit, Cabou Cendrine, Viaud Julien, Gratacap Marie-Pierre, Gaits-Iacovoni Frédérique, Vanhaesebroeck Bart, Payrastre Bernard, Severin Sonia, ;2017;Blood;130;2032-2042; 28903944
  • Lack of phosphatidylinositol 3-kinase VPS34 in regulatory T cells leads to a fatal lymphoproliferative disorder without affecting their development.;Courreges Christina J F, Davenport Elizabeth C M, Bilanges Benoit, Rebollo-Gomez Elena, Hukelmann Jens, Schoenfelder Priya, Edgar James R, Sansom David, Scudamore Cheryl L, Roychoudhuri Rahul, Garden Oliver A, Vanhaesebroeck Bart, Okkenhaug Klaus, ;2024;Frontiers in immunology;15;1374621; 39664390

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).